Loading…
Loading grant details…
| Funder | Department of Biotechnology/Wellcome Trust India Alliance |
|---|---|
| Recipient Organization | Dayanand Medical College & Hospital |
| Country | India |
| Start Date | Oct 01, 2021 |
| End Date | Sep 30, 2026 |
| Duration | 1,825 days |
| Number of Grantees | 1 |
| Roles | Award Holder |
| Data Source | Europe PMC |
| Grant ID | IA/TSG/20/1/600061 |
Epilepsy is common, stigmatizing and often not treated in resource-limited settings. Failure to treat may result in premature mortality. Treatment in primary healthcare is an option, given the lack of specialists.
We aim to determine if a community-based, primary care initiative leads to improved seizure control, adherence and quality of life in people with epilepsy.
We will develop a perpetuating, virtual research centre comprising clinicians, quantitative and qualitative researchers, engineers, health economists, health communication experts and research trainees from 6 organizations with emphasis on training young physicians for future research. A before-after design at three sites in India, with outcome evaluation by mixed methods will be employed.
A preparatory phase will be followed by community screening to identify cases.
Screen positives will be followed during an 18-month observation phase, and subsequently enter an 18-month interventional phase comprising of -training primary health workers in managing epilepsy, community awareness campaigns, and delivery of a technology-enabled care model. The primary outcome will be change in seizure remission rates between the observation and intervention phase.
Quality of life, medication adherence and feasibility, acceptability and cost-effectiveness of the project will also be assessed. Our learnings will inform policy-makers about the effectiveness of the program.
Dayanand Medical College & Hospital
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant